MED - OPTAVIA Net Sales Margin

The popularity of GLP-1 drugs has crashed sales for Medifast, Inc. (MED), creating negative operating leverage and rising costs. Net profit margins on shipments clearly capture this decline, with the current value standing at -13.60. Previously, the business relied on the Optavia subscription model, which guaranteed a steady cash flow. A loyal community and personal coaching ensured high customer retention rates and stable revenue.
Summary analytical data breakdowns for Medifast, Inc (MED)

This indicator reflects the operational efficiency of Medifast, Inc. (MED), measuring the share of net profit in total revenue after covering all expenses. The current value of -13.60 demonstrates a balance between the automation of production lines and the costs of expensive human capital in coaching, which is clearly confirmed by the actual sales margins.